Genfit (GNFT) News Today $3.80 -0.12 (-2.93%) Closing price 02/21/2025 03:57 PM EasternExtended Trading$3.83 +0.03 (+0.68%) As of 02/21/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meetingFebruary 21 at 2:30 AM | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday TradingFebruary 18, 2025 | msn.comGenfit S.A. (NASDAQ:GNFT) Sees Large Increase in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 101,300 shares, a growth of 59.0% from the January 15th total of 63,700 shares. Based on an average trading volume of 8,200 shares, the short-interest ratio is presently 12.4 days. Approximately 0.2% of the shares of the stock are sold short.February 16, 2025 | marketbeat.comCritical Review: Genfit (NASDAQ:GNFT) vs. Omega Therapeutics (NASDAQ:OMGA)February 16, 2025 | americanbankingnews.comEuropean Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for WeekFebruary 14, 2025 | msn.comGENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs HoldersFebruary 14, 2025 | globenewswire.comGenfit's (GNFT) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $13.00 target price on shares of Genfit in a report on Friday.February 7, 2025 | marketbeat.comFY2025 EPS Estimates for Genfit Cut by Leerink PartnrsGenfit S.A. (NASDAQ:GNFT - Free Report) - Stock analysts at Leerink Partnrs reduced their FY2025 earnings per share (EPS) estimates for Genfit in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now expects that the company will earn ($0.88) per share for the year, dowFebruary 7, 2025 | marketbeat.comGENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025February 6, 2025 | globenewswire.comFY2024 EPS Estimates for Genfit Reduced by Leerink PartnrsGenfit S.A. (NASDAQ:GNFT - Free Report) - Stock analysts at Leerink Partnrs reduced their FY2024 EPS estimates for shares of Genfit in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now expects that the company will earn $0.60 per share for the year, down fromFebruary 6, 2025 | marketbeat.comGenfit SA (GNFT) Receives a Rating Update from a Top AnalystFebruary 3, 2025 | markets.businessinsider.comGENFIT Secures €185 Million Royalty Financing Deal to Bolster R&D and Financial StabilityJanuary 30, 2025 | msn.comGENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution PlanJanuary 30, 2025 | globenewswire.comGENFIT Announces 2025 Financial CalendarJanuary 29, 2025 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Sees Significant Growth in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 63,400 shares, a growth of 6.0% from the December 15th total of 59,800 shares. Based on an average daily volume of 10,100 shares, the days-to-cover ratio is currently 6.3 days. Approximately 0.1% of the shares of the company are sold short.January 19, 2025 | marketbeat.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJanuary 13, 2025 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Short Interest Down 6.3% in DecemberGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 59,800 shares, a decline of 6.3% from the November 30th total of 63,800 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 12,300 shares, the days-to-cover ratio is currently 4.9 days.December 31, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Edge Higher in Thursday TradingDecember 26, 2024 | msn.comGenfit (NASDAQ:GNFT) Shares Down 3.8% - Here's What HappenedGenfit (NASDAQ:GNFT) Trading Down 3.8% - Time to Sell?December 12, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Decline in Tuesday TradingNovember 26, 2024 | msn.comGenfit Balances Ipsen Partnership With High-Risk Pipeline AmbitionsNovember 21, 2024 | seekingalpha.comGENFIT S.A.: GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting 2024November 17, 2024 | finanznachrichten.deGENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024November 13, 2024 | globenewswire.comGenfit’s Revenue Surge Driven by Key MilestoneNovember 8, 2024 | markets.businessinsider.comGENFIT Reports Third Quarter 2024 Financial InformationNovember 7, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note FridayNovember 1, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday TradingOctober 30, 2024 | msn.comGenfit S.A. (NASDAQ:GNFT) Sees Significant Increase in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 67,800 shares, a growth of 16.5% from the September 15th total of 58,200 shares. Based on an average daily volume of 10,700 shares, the days-to-cover ratio is presently 6.3 days. Currently, 0.1% of the shares of the company are short sold.October 16, 2024 | marketbeat.comGenfit (GNFT) Earnings Dates & ReportsOctober 16, 2024 | investing.comGenfit's (GNFT) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $13.00 price target on shares of Genfit in a research note on Friday.October 11, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Higher in Friday TradingOctober 4, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Decline in Tuesday TradingOctober 1, 2024 | msn.comGENFIT: Ipsen's Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated ApprovalSeptember 23, 2024 | globenewswire.comLeerink Partnrs Analysts Lift Earnings Estimates for Genfit S.A. (NASDAQ:GNFT)Genfit S.A. (NASDAQ:GNFT - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for shares of Genfit in a report released on Thursday, September 19th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings ofSeptember 23, 2024 | marketbeat.comGenfit (NASDAQ:GNFT) Rating Reiterated by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $13.00 price objective on shares of Genfit in a research report on Friday.September 20, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Poised to End Week HigherSeptember 13, 2024 | msn.comGenfit (NASDAQ:GNFT) Trading Down 2%Genfit (NASDAQ:GNFT) Shares Down 2%September 11, 2024 | marketbeat.comGenfit (NASDAQ:GNFT) Stock Price Down 0.2%Genfit (NASDAQ:GNFT) Trading Down 0.2%August 20, 2024 | marketbeat.comGenfit S.A. (GNFTF)August 16, 2024 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingAugust 6, 2024 | msn.comGENFIT S.A.: Positive Opinion from EMA Committee for Ipsen's Iqirvo (elafibranor) in Primary Biliary CholangitisJuly 27, 2024 | finanznachrichten.deGENFIT: Positive Opinion from EMA Committee for Ipsen's Iqirvo® (elafibranor) in Primary Biliary CholangitisJuly 26, 2024 | globenewswire.comGenfit (NASDAQ:GNFT) Shares Down 3.8% Genfit (NASDAQ:GNFT) Trading Down 3.8%July 24, 2024 | marketbeat.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJuly 9, 2024 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Sees Large Growth in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 89,800 shares, a growth of 5.8% from the May 15th total of 84,900 shares. Currently, 0.2% of the company's shares are short sold. Based on an average trading volume of 19,900 shares, the short-interest ratio is presently 4.5 days.June 18, 2024 | marketbeat.comGENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASHJune 17, 2024 | globenewswire.comFY2027 EPS Estimates for Genfit S.A. Reduced by HC Wainwright (NASDAQ:GNFT)Genfit S.A. (NASDAQ:GNFT - Free Report) - Equities research analysts at HC Wainwright decreased their FY2027 earnings per share (EPS) estimates for Genfit in a note issued to investors on Tuesday, June 11th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per shareJune 13, 2024 | marketbeat.comGENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary CholangitisJune 10, 2024 | globenewswire.comUS FDA approves Genfit and Ipsen's liver disease drugJune 10, 2024 | reuters.comGENFIT to Present Latest ACLF Research at EASL Congress™ 2024May 29, 2024 | globenewswire.com Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address GNFT Media Mentions By Week GNFT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼0.220.60▲Average Medical News Sentiment GNFT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼41▲GNFT Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CureVac News Avid Bioservices News Nuvation Bio News Prothena News Cronos Group News GH Research News Bicara Therapeutics News Verve Therapeutics News Mind Medicine (MindMed) News Dianthus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNFT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genfit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
